Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EYEG | US
0.14
0.38%
Healthcare
Biotechnology
01/01/1970
09/03/2026
35.73
35.58
35.73
35.58
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
3.3%1 month
3.3%3 months
3.1%6 months
3.3%-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.50
Range1M
0.52
Range3M
0.88
Rel. volume
1.55
Price X volume
5.43K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| XOMAP | XOMAP | Biotechnology | 25.885 | 0 | 0.45% | 26.27 | 121.93% |
| XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.3 | 0 | -0.49% | 25.57 | 121.93% |
| SABSW | SABSW | Biotechnology | 0.0318 | 0 | 0.17 | 11.58% | |
| Revolution Medicines Inc. Warrant | RVMDW | Biotechnology | 1.83 | 0 | 1.67% | n/a | 5.40% |
| REVBW | REVBW | Biotechnology | 0.0091 | 0 | n/a | 0.00% | |
| Rocket Pharmaceuticals Inc. Warrant | RCKTW | Biotechnology | 0.0199 | 0 | -0.50% | n/a | 0.00% |
| ICUCW | ICUCW | Biotechnology | 0.0295 | 0 | 7.27% | n/a | -45.50% |
| Humacyte Inc | HUMAW | Biotechnology | 0.1181 | 0 | 8.65% | n/a | -63.37% |
| COEPW | COEPW | Biotechnology | 0.0123 | 0 | 24.24% | n/a | 25.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 3.12 | 72.80 | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | - | 3.66B | - |